Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade

Cancer Causes and Control

Volumn 23, Issue 11, 2012, Pages 1865-1873

  Gilbert, Rebecca ^a   Metcalfe, Chris ^a   Fraser, William D ^b   Donovan, Jenny ^a   Hamdy, Freddie ^c   Neal, David E ^d   Lane, J Athene ^a   Martin, Richard M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

1,25 Dihydroxyvitamn D; Prostate cancer; Retinol; Vitamin D; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CALCITRIOL; PROSTATE SPECIFIC ANTIGEN; RETINOL;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SELF REPORT; VITAMIN BLOOD LEVEL;

CASE-CONTROL STUDIES; GREAT BRITAIN; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; VITAMIN A; VITAMIN D; VITAMIN E;

EID: 84867991736     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0052-5     Document Type: Article

References (25)

1. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 301(1):39-51
2. Willis MS, Wians FH (2003) The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta 330(1-2):57-83 (Pubitemid 36287634)
3. Peehl DM, Feldman D (2003) The role of vitamin D and retinoids in controlling prostate cancer progression. Endocr Relat Cancer 10(2):131-140 (Pubitemid 36758642)
4. Mondul AM, Watters JL, Mannisto S, Weinstein SJ, Snyder K, Virtamo J, Albanes D (2011) Serum retinol and risk of prostate cancer. Am J Epidemiol 173(7):813-821
5. Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB, Peters U (2009) Serum retinol and prostate cancer risk: a nested casecontrol study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 18(4): 1227-1231
6. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjonneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Psaltopoulou T, Trichopoulou A, Trichopoulos D, Palli D, Vineis P, Tumino R, Berrino F, Kiemeney L, Bueno-de-Mesquita HB, Quiros JR, Gonzalez CA, Martinez C, Larranaga N, Chirlaque MD, Ardanaz E, Stattin P, Hallmans G, Khaw KT, Bingham S, Slimani N, Ferrari P, Rinaldi S, Riboli E (2007) Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 86(3): 672-681 (Pubitemid 47435834)
7. World Cancer Research Fund/American Institute for Cancer R (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
8. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE (2009) Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 301(3):102-103
9. Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2):83-95 (Pubitemid 40691207)
10. Stewart LV, Weigel NL (2004) Vitamin D and prostate cancer. Exp Biol Med 229(4):277-284 (Pubitemid 38372891)
11. Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JAC, Metcalfe C (2011) Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 22:319-340
12. Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy FC, Neal DE, Lane JA, Martin RM (2012) Associations of circulating 25-hydroxyvitaminDwith prostate cancer diagnosis, stage and grade. Int J Cancer 131(5):1187-1196. doi:http://dx.doi.org/10.1002/ijc.27327
13. Yin L, Raum E, Haug U, Arndt V, Brenner H (2009) Metaanalysis of longitudinal studies: serum vitamin D and prostate cancer risk. Cancer Epidemiol 33:435-445
14. Need AG, O'Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin BEC (2008) Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 23(11):1859-1863. doi:10.1359/jbmr.080607
15. Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J (2007) A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 4(3):e103
16. Rohde CM, Manatt M, Clagett-Dame M, DeLuca HF (1999) Vitamin A antagonizes the action of vitamin D in rats. J Nutr 129(12):2246-2250
17. Lane JA, Hamdy FC, Martin RM, Turner EL, Neal DE, Donovan JL (2010) Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer 46(17):3095-3101
18. Fraser WD, Durham BH, Berry JL, Mawer EB (1997) Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem 34:632-637 (Pubitemid 27480965)
19. Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA Jr (2005) Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower. JAMA 294(1):66-70 (Pubitemid 41002840)
20. Janssen KJM, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KGM (2010) Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 63(7):721-727
21. Royston P (2009) Multiple imputation of missing values: further update office, with an emphasis on categorical variables. Stata J 9(3):466-477
22. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Baker LH (2011) Vitamin E and the risk of prostate cancer. JAMA 306(14):1549-1556. doi:10.1001/jama.2011.1437
23. Weinstein SJ, Wright ME, Lawson KA, Snyder K, Mannisto S, Taylor PR, Virtamo J, Albanes D (2007) Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16(6):1253-1259 (Pubitemid 46984967)
24. Venkitaraman R, Thomas K, Grace P, Dearnaley DP, Horwich A, Huddart RA, Parker CC (2010) Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance. Tumour Biol 31(2):97-102
25. Watters JL, Gail MH, Weinstein SJ, Virtamo J, Albanes D (2009) Associations between {alpha}-tocopherol, {beta}-carotene, and retinol and prostate cancer survival. Cancer Res 69(9):3833-3841